GENE SIMMONS TAKES INVICTUS ON TOUR
March 25 2019 - 2:48PM
INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company")
(TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to report that
the Company’s Chief Evangelist Officer Gene Simmons is taking
Invictus with him on the KISS End of the Road Tour. The rock legend
and media mogul, recently hosted backstage meetings with Invictus
stakeholders along with Invictus President and Chief Executive
Officer George Kveton and members of the Board prior to and
following the band’s March 22 appearance at Scotiabank Arena.As
Chief Evangelist Officer of Invictus, Mr. Simmons is planning to
meet with the Company’s constituents, partners and stakeholders on
tour stops around the world. “I am devoted to Invictus and my
other business partners, and the tour provides me with an
opportunity to put them on an international stage,” said Mr.
Simmons. “I work around the clock no matter where I am in the
world.”In addition to taking Invictus on tour, Mr. Simmons will
continue to represent the Company at key business and investor
conferences in North America. Past appearances have included
speaking roles at MJBiz in New Orleans and at Money Show
conferences in Las Vegas, San Francisco and Toronto among others.
As a popular and prolific guest on notable business and news media
programming, Mr. Simmons will also continue to represent Invictus
in the media.For more information, please visit
www.invictus-md.com. On Behalf of the Board,George E.
KvetonChief Executive Officer and DirectorJessica MartinVice
President, Public Relations and Regulatory Affairs(833)
879-4363
About Invictus Invictus is a global
cannabis company offering a selection of products under a wide
range of brands. Our integrated sales approach is defined by five
pillars of distribution including medical, adult-use,
international, Licensed Producer to Licensed Producer and retail
stores. Invictus has partnered with business leaders to convey
our corporate vision, including KISS music legend and business
mogul Gene Simmons as our Chief Evangelist Officer. To meet growing
demand, Invictus is expanding its cultivation footprint, with three
cannabis production facilities licensed under the Cannabis Act and
Cannabis Regulations in Canada. To accommodate international sales,
Invictus’ wholly-owned subsidiary, Acreage Pharms Ltd. (“Acreage
Pharms”), has designed and is currently building its Phase 3
purpose-built cultivation facility to be European Union Good
Manufacturing Practices (“EU-GMP”) compliant. The Company is
targeting up to 50 percent of production to medical cannabis. To
ensure consistency in quality and supply, Invictus maintains all
aspects of the growing process through its subsidiary, Future
Harvest Development Ltd. (“Future Harvest”), a high-quality
fertilizer and nutrients manufacturer. Invictus drives sustainable
long-term shareholder value through a diversified product portfolio
with over 70 Health Canada approved strains and a multifaceted
distribution strategy including medical, adult-use, international,
Licensed Producer to Licensed Producer and retail stores. For more
information visit www.invictus-md.com. Neither the TSX Venture
Exchange nor its Regulation Services Provider accepts
responsibility for the adequacy or accuracy of this release.
Jessica Martin
Invictus
(833) 879-4363
jessica@invictus-md.com
Invictus MD Strategies (TSXV:GENE)
Historical Stock Chart
From Aug 2024 to Sep 2024
Invictus MD Strategies (TSXV:GENE)
Historical Stock Chart
From Sep 2023 to Sep 2024